Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seacoast Technologies was a medical device company based in Portsmouth, New Hampshire, that specialized in minimally invasive surgical tools. The company is best known for developing the VasoView system, a pioneering technology for endoscopic vessel harvesting (EVH) used in coronary artery bypass graft (CABG) surgeries. By allowing surgeons to harvest veins or arteries through small incisions rather than long traditional incisions, the technology significantly reduced patient trauma, scarring, and recovery time. In 1996, Seacoast Technologies was acquired by Origin Medsystems, a subsidiary of Guidant Corporation, for approximately $15 million. The VasoView product line remains a market leader in the EVH space today under the ownership of Getinge.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seacoast Technologies.